1 RP HPLC Purification of Small Molecules Lou Cheng Astrazeneca R&D Boston.

Post on 27-Mar-2015

225 views 1 download

Transcript of 1 RP HPLC Purification of Small Molecules Lou Cheng Astrazeneca R&D Boston.

1

RP HPLC Purification of Small Molecules

Lou Cheng

Astrazeneca R&D Boston

2

HPLC Basics: Classification, k, α, N, Rs

Reversed-Phase HPLC – Isocratic and Gradient

Analytical Method Development – Screening & Optimization

Analytical Scale-up of Optimized HPLC Method

From Analytical Scale-up to PrepLC Purification

PrepLC Purification – Fraction Collection & Recovery

Summary

Outline

3

HPLC Basics - Classification

Nonionic polarNonpolar Ionic

Water-insoluble Water-soluble

Increasing polarity

AdsorptionPartition

IonExchange

[ NP Partition]

[ RP Partition]

Size Exclusion

[Gel Permeation] [Gel Filtration]

Mo

lecu

lar

Wei

gh

t

102

103

104

105

106

4

HPLC Basics - Classification

Nonionic polarNonpolar Ionic

Water-insoluble Water-soluble

Increasing polarity

AdsorptionPartition

IonExchange

[ NP Partition]

[ RP Partition]

Size Exclusion

[Gel Permeation] [Gel Filtration]

Mo

lecu

lar

Wei

gh

t

102

103

104

105

106

5

Retention factor

tRi - t0k = t0

k2α =

k1

Selectivity

N = 162t

Wi

Efficiency

Rs = 0.25 (-1)N0.5 kk + 1

Resolution

tR1

tR2

t0

w1 w2

Minutes0 10

mV

olt

sHPLC Basics – k, α, N, Rs

6

k: retention factorkw: retention factor by 100% water as mobile phase (φ = 0)S: a constant for a given sample compoundφ : organic fraction (volume) in binary mobile phase

log k = log kw – Sφ Eq. 1*

Kw: Hydrophobicity

Reversed-Phase HPLC – Isocratic

S: Sensitivity to change of mobile phase strength

*Ref: Practical HPLC Method Development, Lloyd Snyder, etc. Wiley, New York, 1997.

7

F

O

N S

OO

NH

O

ID: 2146-197 (BCL2)

(MW = 426.5)

Log k = log kw – Sφ

N

N

O

O

NHNH

NH

O

Cl Cl (MW = 454.3)

Code: 1862-191-1 (CoaD) 0.30 0.35 0.40 0.45 0.50 0.55 0.60

-1.0

-0.5

0.0

0.5

1.0

Kw = 933, S = 4.53

0

3

6

9

12

15

0.30 0.35 0.40 0.45 0.50 0.55 0.60

-1.0

-0.5

0.0

0.5

1.0

kw = 2290, S = 7.85

log

k

0

3

6

9

12

15

Re

ten

tion

Fa

ctor (k)

Conditions: HPChem 10, XBridge C8, 4.6 × 50 mm, 10 mM NH4Form/AcN, 1.0 mL /min

Rule of Adjusting Isocratic Retention by φ: 5% Ξ 100 % k

Isocratic RP HPLC - AZ Example 1

8

0.10 0.15 0.20 0.25 0.30 0.35 0.400.0

0.5

1.0

1.5

log

k

0

10

20

30

40

50

Retention F

actor (k)Kw = 28S = 3.35

Kw = 62, S = 3.67Kw = 72, S = 3.72

02154-137, 10 g (HE-TMK)

N N

ClCl

N N

ClO

N N

OCl

Mw = 163

Mw = 158

Mw = 158

+

log k = log kw – Sφ

Conditions: XBridge C18, 4.6 × 50 mm, 0.1% NH4OH/MeOH Flow Rate: 1.0 ml /min, room temperature.

The Kw and S of the two isomers are too close to be separable by RP gradient runs.

Isocratic RP HPLC - AZ Example 2

9

Reversed-Phase HPLC – Gradient

*By assuming S = 4 for all small molecules, one gradient run is sufficient to resolve kw Two gradient runs can solve kw and S, by assuming log k/φ linear relationship

Automatic method development

Retention Prediction (Drylabs, Chromsword)

b = SVm/tGF log k0 = log kw - S0

tR = (t0/b) log [2.3k0b(ts/t0) + 1] + ts + tD Eq. 2*

T0: column dead volumn; b: gradient steepness; k0: k at the beginning of the gradient; ts: value of tR for a nonretained solute; tD: dwell time for gradient elution; : change of organic percentage in the mobile phase; S: system constant; Vm: column dead volumn; tG: gradient time; F: flow rate.

For Linear Solvent Strength (LSS) Gradient:

*Ref: Practical HPLC Method Development, Lloyd Snyder, etc. Wiley, New York, 1997.

10

Retention Prediction of Gradient RP HPLC - AZ Examples

Sample

b tG tR, predicted tR, Exp

Error (%)(%/min) (%) (min.) (min.) (min.)

2146-197 (BCL2)

(Kw = 933, S = 4.53)

6.0 35-65 5 2.55 2.56 -0.3

12.0 35-95 5 2.28 2.35 -3.0

1862-191-1 (CoaD)

(Kw = 2290, S = 7.85)

9.0 50-95 5 3.00 2.82 +6.4

6.0 40-70 5 4.41 4.42 -0.2

Conditions: HPChem 10, XBridge C8, 4.6 × 50 mm, 10 mM NH4Form/AcN, 1.0 mL /min, room temperature. t0 = ts = 0.6 min, tD = 1.2 min.

tR = (t0/b) log [2.3k0b(ts/t0) + 1] + ts + tD

11

Why Gradient?

Flexibility (b, , 0) to optimize separation with minimal effects on efficiency (N)

Samples with a wide k range, sometimes containing late-eluting interferences that

can either kill the column or carryover to subsequent runs

More precise, robust, and automatable

Dilute solutions of sample dissolved in a weak solvent

Gradient RP run is the best starting point for method development

Reversed-Phase HPLC – Gradient Over Isocratic

12

B: ACNC: MeOHD: THF/H2O (9/1)

SolventsColumn Examples

1: XBridge C18

2: Gemini C6-Phenyl3: Atlantic dC18

4: YMC ODS AQ5: Synergi Hydro-RP6: YMC Carotenoid (C30)●●●●●●

162 conditions can be screened for one sample if necessary

RP HPLC Analytical Method Development – Screening

E: 0.1% TFAF: 0.1% Formic AcidG: 10 mM NH4Ac pH8H: 0.1% TEAJ: 0.1% NH4FormK: 0.1% NH4OHL: 10 mM NH4Ac/HOAc pH5M: 20 mM NH4AcN: 10 mM (NH4)2CO3

Valves: G1159A 6-ColSelector, G1160A, 12/13 SelvalvesDetectors: Agilent MSD and Sedex 75 ESDL Detector, Finnigan AQA mass spectrometer by closed contact Waters MicroMass Massspectrometer NP, chiral, SFC have similar settings

13

Criteria for Evaluating and Optimizing HPLC Methods

General:• Low k, low tailing factor, high N

• High α, high Rs

Client-specific:

Clear communication with clients is a prerequisite to successful method development

●●●●●●

• MPS/library (universal applicability)

• Fraction collection for one component, multiple components, or all components?

• Purity/Recovery?

• pH stability of the desired components?

• Amount of the sample (high loading)

14

AZ Example of Screening Sequence (2252-026)

15

From Screening To PrepLC

Anal. Scale-up100 mg/ml, 4.6 × 100 mm XBridge C1830-80% MeOH, 10 min, 1 ml/min

Screening

2252-026 (QuinFF)0.8 mg/ml, XBridge C18 (4.6 × 50 mm)5-95% MeOH/10 mM HCOONH4, 5 minutes, 1.0 ml/min, 240 nm.

N

N

OH

Br

O

O

Tracked by MSD

*

*

*

Rs

1.8 Rs

2.2

Optimization

30-80% MeOH

Rs

3.6Rs

4.8

PrepLC19 × 100 mm XBridge C1830-80% MeOH, 10 min20 ml/min, 100 mg/ml

Baseline Resolution

16

From Screening To PrepLC

Scale-up/loading100 mg/ml, 4.6 × 100 mm XBridge C1830-80% MeOH, 10 min, 1 ml/min

Screening

2252-026 (QuinFF)0.8 mg/ml, XBridge C18 (4.6 × 50 mm)5-95% MeOH/10 mM HCOONH4, 5 minutes, 1.0 ml/min, 240 nm.

N

N

OH

Br

O

O

Tracked by MSD

*

*

*

Rs

1.8 Rs

2.2

Optimization

30-80% MeOH

Rs

3.6Rs

4.8

PrepLC19 × 100 mm XBridge C1830-80% MeOH, 10 min20 ml/min, 100 mg/ml

Baseline Resolution

17

Analytical Scale-up of Optimized HPLC Method

Goal: 1) Is the optimized analytical HPLC method good for preparative one? 2) If it is, what is the maximum loading for touching-band separation?

Optimization

EN00059-12Synergi Hydro-RP (4.6 × 50 mm)30-60% MeOH/TFA, 5 min, 1.0 ml/min, 240 nm, 0.6 mg/ml.

Product (MW =471.5)

Anal. Scale-up

Synergi Hydro-RP (4.6 × 100 mm)30-60% MeOH/TFA, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

Product

This method is not practical for separation of 5 gram samples! (125 prep injections for 19 × 100mm column!)

18

Scale-up of Optimized HPLC Method – Search for the Best

Optimization Anal. Scale-up

Gemini C6-Phenyl (4.6 × 50 mm)50-70% MeOH/NH4OH, 5 min, 1.0 ml/min, 240 nm, 0.6 mg/ml.

Gemini C6-Phenyl (4.6 × 100 mm)50-70% MeOH/NH4OH, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

XBridge C18 (4.6 × 100 mm)30-60% CH3OH/NH4OH, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

XBridge C18 (4.6 × 50 mm)30-60% CH3CN/NH4OH, 5 min, 1.0 ml/min, 240 nm,5ul inj, 0.6 mg/ml

19

Gilson PrepLC via UV-triggered Fraction Collection

EN00059-12XBridge C18 (50 × 250 mm)30-60% CH3CN/NH4OH, 25 min, 100 ml/min, 240 nm, 6.0 ml, 160 mg/ml.Only 5 injections!

20

Scale-up of Optimized HPLC Method – Theoretical Aspects

W

TR

W2 = W02 + Wth

2 Eq. 3

= 16 N-1 t02 (1 + 0.5 k)2 + 0.9 t0

2 k2 w ws-1

(column effect) (sample-weight effect)

Ws: column saturation capacity ( ≈ 0.4 surface area)

Overloading in reality may include mass overloading, and others. volume overloading,

21

Optimized Analytical

2146-197 (BCL2)Xbridge C8 (4.6 × 50mm)20-50% CH3CN/NH4Ac (pH 8)5min, 1 ml/min, 254 nm, ~1 mg/ml5 μl injection

Loading of Analytical Scale-up - Theoretical vs. Practical

Scale Up2146-197 (BCL2)Xbridge C8, 4.6 × 100mm20-50% CH3CN/NH4Ac (pH 8)10 min, 1 ml/min, 254 nm, ~70 mg/mlInj Vol: 20 μl (Vth = 90 μl)

Rs3.5

Product

What is the maximum loading of touching-band separation?

*

*

22

2146-197 (BCL2)Xbridge C8, 4.6 × 100mm20-50% CH3CN/NH4Ac (pH 8)10 min, 1 ml/min, 254 nm, ~70 mg/mlInj Vol: 5 μl, 10 μl, 15 μl, 20 μl

5 μl

10 μl

15 μl

20 μl

10 μl: Baseline separation

Analytical Scale-up of Optimized HPLC Method - Mass Loading Studies

15 μl: Touching-band separation 20 μl: No separation

*

*

*

Rt

23

From Analytical Scale-up to PrepLC

F = (dprep/danal)2 x Lprep/Lanal

Constant:Constant:•Column chemistryColumn chemistry•Particle sizeParticle size•Sample concentration

To scale:To scale:•Flow rate•Injection volume

4.6 × 100 mm

19 × 100 mm

50 × 100 mm

VTB, 1 ml/min

17 VTB, 17 ml/min

118 VTB, 118 ml/min

× Fsemi

× Flarge

2146-197 (BCL2)XBridge C8, 20-50% CH3CN/NH4Ac (pH 8), 10 min, 20 ml/min, ~70 mg/ml, GilsonTM LC

Baseline Separation

200 (255) μl, 20 (17) ml/min, 19 × 100 mm15 μl, 1 ml/min, 4.6 × 100 mm

2146-197 (BCL2)XBridge C820-50% CH3CN/NH4Ac (pH 8) 10 min, 1.0 ml/min~70 mg/ml, Agilent 1100

24

PrepLC Purification - UV-triggered Fraction Collection

XBridge C18 (50 × 250 mm)30-60% CH3CN/NH4OH, 25 min, 100 ml/min, 240 nm, 6.0 ml, 160 mg/ml.

2597 % Recovery (91 % without first fraction)

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5

0.0

5.0k

10.0k

15.0k

20.0k

25.0k

30.0k

Y = 6580 X - 65, r = 0.99994

Abs

orba

nce

@ 3

10 n

m

Concentration (mg/ml)

PrepLC Purification - Fraction Analysis & Recovery

26

PrepLC Purification - MS-triggered Fraction Collection

27

PrepLC Purification - MS-triggered Fraction Collection

Recovery 80 %

28

Summary

Screening Optimization Anal. Scale-up Prep LC

Gradient RP analytical run is the best starting point for developing PrepLC method Screening, optimization, and scale-up are effective steps toward PrepLC method

development┐ The best analytical methods are not always the best PrepLC methods, and scale-up

experiments are imperative to validate the performance and loading of the analytical method under PrepLC conditions

UV-triggered fraction collection has high recovery and lower purity than MS-triggered fraction collection.

29

Acknowledgment

Members of Analytical Group: Tatyana, Camil, Nancy, Mark, Sharon, Milena, Ziling.

Randstad USA: Yushen Chang, Vincent Cianciaruso.

30

31

Analytical Method Screening - Results

XBridge C18 (4.6 × 50 mm)5-95% NH4OH/AcN, 5 min, 1.0 ml/min, 240 nm.

Gemini C6-Phenyl (4.6 × 50 mm)5-95% NH4OH/MeOH, 5 min, 1.0 ml/min, 240 nm.

Atlantis dC18 (4.6 × 50 mm)5-95% NH4Fm/MeOH, 5 min, 1.0 ml/min, 240 nm.

Synergi Hydro-RP (4.6 × 50 mm)5-95% TFA/MeOH, 5 min, 1.0 ml/min, 240 nm.

Luna C6-Phenyl (4.6 × 50 mm)5-95% AcONH4/MeOH, 5 min, 1.0 ml/min, 240 nm.

Curosil PFP (4.6 × 50 mm)5-95% HCOOH/CH3CN, 5 min, 1.0 ml/min, 240 nm.

32

Analytical Method Optimization

XBridge C18 (4.6 × 50 mm)30-60% NH4OH/AcN, 5 min, 1.0 ml/min, 240 nm,5ul inj, 0.5 mg/ml

Gemini C6-Phenyl (4.6 × 50 mm)50-70% NH4OH/MeOH, 5 min, 1.0 ml/min, 240 nm.

Atlantis dC18 (4.6 × 50 mm)50-95% NH4Fm/MeOH, 5 min, 1.0 ml/min, 240 nm.

Synergi Hydro-RP (4.6 × 50 mm)30-60% TFA/MeOH, 5 min, 1.0 ml/min, 240 nm.

33

Analytical Scale-up of Optimized Analytical Methods

XBridge C18 (4.6 × 100 mm)30-60% NH4OH/AcN, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

Gemini C6-Phenyl (4.6 × 100 mm)50-70% NH4OH/MeOH, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

Synergi Hydro-RP (4.6 × 100 mm)30-60% TFA/MeOH, 10 min, 1.0 ml/min, 240 nm, 12.5 ul, 160 mg/ml.

34

EN00065-01-1cGemini C6-Phenyl (4.6X100mm)40-50% CH3CN/0.1% HCOOH14 min, 1 ml/min, 254 nm, ~30 mg/mlInj Vol: 3 μl, 6 μl, 12.5 μl, 25 μl

Analytical Scale-up of Optimized HPLC Method - Volume Loading

Rt

35

Effects of Buffer Concentration on Preparative Loadability

AG-166Gemini C6-Phenyl (4.6X100mm), 0-20% CH3CN, 20 min, 1 ml/min, 254 nm, 12 ul, ~100 mg/ml0% HCOOH 0.05% HCOOH0.1% HCOOH0.2% HCOOH

36

Screening

1862-191-1 (CoaD)

1JB059551JB259551JB50955

Optimization

1JB606051JB505051JB40405

Scale-up/loading

4.6 × 100 mm XBridge C1840% AcN, 60% NH4Form, 30 min, 1 ml/min, 200 mg/ml

Purification

19 × 250 mm XBridge C1840 % AcN, 100 ml/min100 min, 1.0 ml (200mg/ml)

Difficult Purifications: Example 2

4.6 × 50 mm XBridge C1810mM NH4Form, 5min, 1 ml/min, 200 mg/mL

4.6 × 50 mm XBridge C1810mM NH4Form, 5min, 1 ml/min, 200 mg/mL

37

Valves: G1159A 6-ColSelector, G1160A, 12/13 SelvalvesDetectors: Agilent MSD and Sedex 75 ESDL Detector Finnigan AQA mass spectrometer by closed contact

NP Chiral HPLCSolvent: HX, MeOH/EtOH(1/1), IPA, 0.1% DiethylamineDetectors: Advanced Laser Polarimeter, PDR_Chiral IncColumns: Chiralpak AD Chiralpak OD, Chiralpak AS, Chiralpak IA, Chiralpak IB, Chiralcel OD, Chiralcel OJ, Regis Pirkle covalent (S,S) whelk O2 10/100 FEC, Regis Pirkle covalent (S,S) whelk O1 5/100, Regis (S,S) ULMO 5/100,Regis (S,S) DACH DNB 5/100, Phenomenex Chirex ®-PGLY and DNB, Large 5cm X 50cm Prep Columns: Chiralpak AD Chiralpak OD, Chiralpak AS, Chiralcel OJ

NP Columns: Luna silica 10/100, YMC-PVA-sil 5/120, YMC-Pak Diol 5/60, YMC-Pak CN 5/120, Luna NH2 5/100, PrincetonSFC Pyridine 5/60

SFC Columns: Berger silica, Diol, CN, Pyridine, Chiralpak AD-H

38

0.1% NH4OH 10mM NH4Form 0.1% FA 0.1% TFA MeOH k1 k2 k3 Rs(2,3)

Xbridge C18 95-60% 5-40% 7.76 9.4 9.8 1.6

80-60% 20-40% 4.75 6.9 7.51 1.8

60% 40% 1.43 2.27 2.56 1.15

70% 30% 2.73 4.74 5.545 1.78

75% 25% 3.8 6.81 7.92 2.07

80% 20% 5.59 10.39 12.16 2.29

85% 15% 8.76 16.83 19.75 2.35

90% 10% 15 29.57 34.66 2.3

75% 25% (Acn)

75% 25% 5.15 5.73 1.75

75% 25% 6.52 7.60 2.11

75% 25% 6.61 7.72 2.15

Atlantis T3 75% 25% 10.92 12.67 2.29

75% 25% 11.24 13.01 2.32

75% 25% 11.55 13.37 2.31

Atlantis D2 75% 25% 5.2 5.77 1.28

85% 15% 11.21 12.47 1.55

YMC ODS AQ 75% 25% 5.63 6.31 1.52

Xbridge C8 75% 25% 5.54 6.46 2.13

1.5 (no separation)

Performance

Column

Method Optimization Summary for 02154-137

39

02154-137 Gradient Runs

Gradient and Isocratic Runs for 02154-137

5-40 % MeOH, Rs = 1.620-40 % MeOH, Rs = 1.8

XBridge C18, 4.6 × 50 mm, 0.1% NH4OH, 5 min, 1.0 ml /min.

02154-137 Isocratic Runs

40 % MeOH, Rs = 1.1520 % MeOH, Rs = 2.2910 % MeOH, Rs = 2.30

XBridge C18, 4.6 × 50 mm, 0.1% NH4OH, 1.0 ml /min.

20 % MeOH

10 %

40 %

40

From Scale-up to Gilson Separation for 02154-137

2154-137 (HE-TMK)XBridge C18, 4.6 × 100mm20 % MeOH/0.1% NH4OH20 min, 1 ml/min, 254 nm, 100 mg/mlInj Vol: 8 μl, 12.5 μl, 25 μl Agilent HP 1100

2154-137 (HE-TMK)XBridge C18, 50 × 250mm20 % MeOH/0.1% NH4OH50 min, 100 ml/min, 254 nm, Inj Vol: 1.5 (1.6) ml,100 mg/ml)GilsonTM LS System

Touching-band loading still lowRetention still too large

NP HPLC in progress!